Non-Current Assets

PP&E (Net)

Kailera Therapeutics PP&E (Net) decreased by 5.2% to $1.85M in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2025
Last reportedQ1 2026May 26, 2026

How to read this metric

An increase indicates ongoing investment in physical capacity, whereas a decline may suggest aging assets or a strategy of asset-light operations.

Detailed definition

This metric represents the book value of tangible assets after subtracting accumulated depreciation from the total histo...

Peer comparison

Standard line item for all manufacturing and industrial companies; directly comparable across peers.

Metric ID: property_plant_equipment_net

Historical Data

2 periods
 Q4 '25Q1 '26
Value$1.96M$1.85M
QoQ Change—-5.2%
Range$1.85M – $1.96M

PP&E (Net) at Other Companies

GE Vernova logo
GE VernovaGEVView metric
Cboe Global Markets logo
Cboe Global MarketsCBOEView metric
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHCView metric
Akamai Technologies logo
Akamai TechnologiesAKAMView metric
General Motors logo
General MotorsGMView metric
Home Depot logo
Home DepotHDView metric

Frequently Asked Questions

What is Kailera Therapeutics 's pp&e (net)?
Kailera Therapeutics (KLRA) reported pp&e (net) of $1.85M in Q1 2026.
What does pp&e (net) mean?
The current book value of physical assets after accounting for wear and tear.